GlassScriptPhysician profile
Amy Rothstein
NPI 1871218115
$4,472.93
in general payments reported to CMS, 2019-2025
27 companies · $1,475 in 2025
The $1,475 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $768 · 2024: $2,230 · 2025: $1,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,920 · Travel and Lodging: $220 · Education: $205 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $112 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,920.24 |
| Travel and Lodging | $219.56 |
| Education | $204.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $111.79 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $727.70 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $684.63 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $420.69 | 2023-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $358.28 | 2023-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $343.03 | 2023-2025 | |
| Pfizer INC. | $282.96 | 2023-2025 | |
| Progenics Pharmaceuticals, INC. | $214.24 | 2024-2025 | |
| Accord Healthcare, INC. | $187.63 | 2024 | |
| Urogen Pharma, INC. | $175.75 | 2023-2025 | |
| Boston Scientific Corporation | $173.86 | 2023-2025 | Spaceoar Vue System - 10ml, Solyx Sis System, Axonics |
| Tolmar, INC. | $117.37 | 2024-2025 | Eligard, Jatenzo |
| Abbvie INC. | $102.55 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $81.67 | 2024-2025 | Provenge |
| Janssen Pharmaceuticals, INC | $78.23 | 2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $75.79 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $71.65 | 2023-2024 | Lynparza |
| Novartis Pharmaceuticals Corporation | $64.64 | 2025 | |
| Teleflex LLC | $60.73 | 2023 | Urolift |
| Merck Sharp & Dohme LLC | $49.56 | 2023-2025 | Lynparza, Keytruda |
| Lantheus Medical Imaging, INC. | $33.06 | 2024 | |
| Antares Pharma, INC. | $32.86 | 2025 | Xyosted |
| Halozyme INC | $31.26 | 2023 | |
| Endo USA, INC. | $27.87 | 2025 | Aveed, Xiaflex |
| Bluewind Medical | $25.18 | 2025 | Revi |
| Verity Pharmaceuticals INC. | $21.77 | 2025 | Trelstar |
| Amgen INC. | $15.20 | 2023 | Prolia, Evenity |
| Myriad Genetic Laboratories, INC. | $14.77 | 2024 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.